IDH1 Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
46Targets
958Trials
16Drugs
0Datasets
4,188Sources
10,439Claims
10,589Evidence
1,574Hypotheses
HYPOTHESISunder reviewmechanismKDM6A

risperidone × KDM6A affinity via computational screening (Boltz-2)

Description

Boltz-2 iPTM ~0.9 for risperidone against KDM6A. Aggregates all screening calls in this iPTM band. Status=under_review until Chai-1 orthogonal validation (gated by hypothesis_action_generator).

Rationale

Boltz-2 structural prediction promoted to hypothesis for Chai-1 orthogonal validation + retrosynth + selectivity gating.

Related claims (16)

TypePredicateConfSource
protein interactionboltz2_ppi_iptm90%dell_ppi:20260503:KDM6A_CAT__TP53_CTD_result
protein interactionboltz2_ppi_iptm90%dell_ppi:20260429:KDM6A_CAT__SMN1_YGBOX_result
protein interactionboltz2_ppi_iptm89%dell_ppi:20260504:TP53_CTD__KDM6A_CAT_result
protein interactionboltz2_ppi_iptm86%dell_ppi:20260503:KDM6A_CAT__SMN1_TUDOR_result
protein interactionboltz2_ppi_iptm84%dell_ppi:20260505:KDM6A_CAT__NRG1_EGF_result
protein interactionboltz2_ppi_iptm84%dell_ppi:20260506:KDM6A_CAT__MDM2_NTD_result
protein interactionboltz2_ppi_iptm76%dell_ppi:20260506:KDM6A_CAT__PAK1_PBD_result
protein interactionboltz2_ppi_iptm75%dell_ppi:20260428:TP53_TAD__KDM6A_CAT_result
protein interactionboltz2_ppi_iptm73%dell_ppi:20260505:KDM6A_CAT__TP53_TAD_result
protein interactionboltz2_ppi_iptm73%dell_ppi:20260502:KDM6A_CAT__IGF1R_ECD_result
protein interactionboltz2_ppi_iptm73%dell_ppi:20260427:TP53_OD__KDM6A_CAT_result
protein interactionboltz2_ppi_iptm72%dell_ppi:20260502:KDM6A_CAT__TP53_OD_result
protein interactionaf3_iptm29%af3_archive_kdm6a_full_x_tet2_cat
protein interactionaf3_iptm10%af3_archive_kdm6a_cat_x_idh1_cat
otheraf3_iptm10%af3_archive_kdm6a_cat_x_idh1_cat
otheraf3_iptm9%af3_03_KDM6A_CHRNA1ecd_Boltz076_2026-04-22_2056